Q9NUD9 (PIGV_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 90.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: GPI mannosyltransferase 2 EC=2.4.1.- Alternative name(s): GPI mannosyltransferase II Short name=GPI-MT-II Phosphatidylinositol-glycan biosynthesis class V protein Short name=PIG-V | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 493 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Alpha-1,6-mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the second mannose to the glycosylphosphatidylinositol during GPI precursor assembly. Ref.6 Ref.7 |
| Pathway | Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein Ref.7. |
| Post-translational modification | Not N-glycosylated. Ref.7 |
| Involvement in disease | Hyperphosphatasia with mental retardation 1 (HPMRS1) [MIM:239300]: A severe syndrome characterized by elevated serum alkaline phosphatase, severe mental retardation, seizures, hypotonia, facial dysmorphism, and hypoplastic terminal phalanges. |
| Sequence similarities | Belongs to the PIGV family. |
| Sequence caution | The sequence CAI21625.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI21626.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI21627.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
| Keywords | |
|---|---|
| Biological process | GPI-anchor biosynthesis |
| Cellular component | Endoplasmic reticulum Membrane |
| Disease | Disease mutation Mental retardation |
| Domain | Transmembrane Transmembrane helix |
| Molecular function | Glycosyltransferase Transferase |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | C-terminal protein lipidation Traceable author statement. Source: Reactome preassembly of GPI anchor in ER membraneTraceable author statement. Source: Reactome |
| Cellular_component | endoplasmic reticulum membrane Inferred from direct assay Ref.7. Source: UniProtKB integral to membraneNon-traceable author statement Ref.7. Source: UniProtKB |
| Molecular_function | mannosyltransferase activity Inferred from mutant phenotype Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 493 | 493 | GPI mannosyltransferase 2 | PRO_0000246234 | |||||
Regions | |||||||||
| Topological domain | 1 – 13 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 14 – 34 | 21 | Helical; Potential | ||||||
| Topological domain | 35 – 77 | 43 | Lumenal Potential | ||||||
| Transmembrane | 78 – 98 | 21 | Helical; Potential | ||||||
| Topological domain | 99 – 113 | 15 | Cytoplasmic Potential | ||||||
| Transmembrane | 114 – 134 | 21 | Helical; Potential | ||||||
| Topological domain | 135 – 136 | 2 | Lumenal Potential | ||||||
| Transmembrane | 137 – 157 | 21 | Helical; Potential | ||||||
| Topological domain | 158 – 161 | 4 | Cytoplasmic Potential | ||||||
| Transmembrane | 162 – 182 | 21 | Helical; Potential | ||||||
| Topological domain | 183 – 192 | 10 | Lumenal Potential | ||||||
| Transmembrane | 193 – 213 | 21 | Helical; Potential | ||||||
| Topological domain | 214 – 234 | 21 | Cytoplasmic Potential | ||||||
| Transmembrane | 235 – 255 | 21 | Helical; Potential | ||||||
| Topological domain | 256 – 327 | 72 | Lumenal Potential | ||||||
| Transmembrane | 328 – 348 | 21 | Helical; Potential | ||||||
| Topological domain | 349 – 378 | 30 | Cytoplasmic Potential | ||||||
| Transmembrane | 379 – 399 | 21 | Helical; Potential | ||||||
| Topological domain | 400 – 469 | 70 | Lumenal Potential | ||||||
| Transmembrane | 470 – 490 | 21 | Helical; Potential | ||||||
| Topological domain | 491 – 493 | 3 | Cytoplasmic Potential | ||||||
Natural variations | |||||||||
| Natural variant | 256 | 1 | Q → K in HPMRS1. Ref.9 | VAR_064190 | |||||
| Natural variant | 341 | 1 | A → E in HPMRS1. Ref.9 | VAR_064191 | |||||
| Natural variant | 341 | 1 | A → V in HPMRS1. Ref.9 | VAR_064192 | |||||
| Natural variant | 385 | 1 | H → P in HPMRS1. Ref.9 | VAR_064193 | |||||
Experimental info | |||||||||
| Mutagenesis | 66 | 1 | W → L: Loss of function. Ref.7 | ||||||
| Mutagenesis | 67 | 1 | D → A: Loss of function. Ref.7 | ||||||
| Mutagenesis | 293 – 294 | 2 | PP → TA: N-glycosylated due to the creation of an acceptor site for N-glycosylation. | ||||||
| Mutagenesis | 308 | 1 | Q → A: Induces a reduces enzyme activity. Ref.7 | ||||||
| Mutagenesis | 312 | 1 | W → L: Loss of function. Ref.7 | ||||||
| Sequence conflict | 33 | 1 | I → T in BAA91196. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [2] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [5] | "Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits." Mabry C.C., Bautista A., Kirk R.F., Dubilier L.D., Braunstein H., Koepke J.A. J. Pediatr. 77:74-85(1970) [PubMed] [Europe PMC] [Abstract] Cited for: DESCRIPTION OF HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME. |
| [6] | "Saccharomyces cerevisiae Ybr004c and its human homologue are required for addition of the second mannose during glycosylphosphatidylinositol precursor assembly." Fabre A.-L., Orlean P., Taron C.H. FEBS J. 272:1160-1168(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol." Kang J.Y., Hong Y., Ashida H., Shishioh N., Murakami Y., Morita Y.S., Maeda Y., Kinoshita T. J. Biol. Chem. 280:9489-9497(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, LACK OF GLYCOSYLATION, MUTAGENESIS OF TRP-66; ASP-67; 293-PRO-PRO-294; GLN-308 AND TRP-312. |
| [8] | "Hyperphosphatasia with seizures, neurologic deficit, and characteristic facial features: Five new patients with Mabry syndrome." Thompson M.D., Nezarati M.M., Gillessen-Kaesbach G., Meinecke P., Mendoza R., Mornet E., Brun-Heath I., Squarcioni C.P., Legeai-Mallet L., Munnich A., Cole D.E. Am. J. Med. Genet. A 152:1661-1669(2010) [PubMed] [Europe PMC] [Abstract] Cited for: DESCRIPTION OF HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME. |
| [9] | "Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome." Krawitz P.M., Schweiger M.R., Rodelsperger C., Marcelis C., Kolsch U., Meisel C., Stephani F., Kinoshita T., Murakami Y., Bauer S., Isau M., Fischer A., Dahl A., Kerick M., Hecht J., Kohler S., Jager M., Grunhagen J. Robinson P.N.Nat. Genet. 42:827-829(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS HPMRS1 LYS-256; VAL-341; GLU-341 AND PRO-385. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK000484 mRNA. Translation: BAA91196.1. AL034380 Genomic DNA. Translation: CAB92120.1. AL034380 Genomic DNA. Translation: CAI21625.1. Sequence problems. AL034380 Genomic DNA. Translation: CAI21626.1. Sequence problems. AL034380 Genomic DNA. Translation: CAI21627.1. Sequence problems. CH471059 Genomic DNA. Translation: EAX07790.1. CH471059 Genomic DNA. Translation: EAX07791.1. CH471059 Genomic DNA. Translation: EAX07792.1. BC013568 mRNA. Translation: AAH13568.1. |
| IPI | IPI00100298. |
| RefSeq | NP_001189483.1. NM_001202554.1. NP_060307.2. NM_017837.3. |
| UniGene | Hs.259605. Hs.732254. |
3D structure databases | |
| ProteinModelPortal | Q9NUD9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000078527. |
Protein family/group databases | |
| CAZy | GT76. Glycosyltransferase Family 76. |
PTM databases | |
| PhosphoSite | Q9NUD9. |
Polymorphism databases | |
| DMDM | 74752975. |
Proteomic databases | |
| PaxDb | Q9NUD9. |
| PRIDE | Q9NUD9. |
Protocols and materials databases | |
| DNASU | 55650. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000078527; ENSP00000078527; ENSG00000060642. ENST00000374145; ENSP00000363260; ENSG00000060642. ENST00000430292; ENSP00000399067; ENSG00000060642. ENST00000431541; ENSP00000388425; ENSG00000060642. ENST00000455364; ENSP00000406080; ENSG00000060642. |
| GeneID | 55650. |
| KEGG | hsa:55650. |
| UCSC | uc001bmz.3. human. |
Organism-specific databases | |
| CTD | 55650. |
| GeneCards | GC01P027113. |
| H-InvDB | HIX0159960. |
| HGNC | HGNC:26031. PIGV. |
| MIM | 239300. phenotype. 610274. gene. |
| neXtProt | NX_Q9NUD9. |
| Orphanet | 247262. Hyperphosphatasia intellectual deficiency syndrome. |
| PharmGKB | PA134952230. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG5542. |
| HOGENOM | HOG000232162. |
| HOVERGEN | HBG080592. |
| InParanoid | Q9NUD9. |
| KO | K07542. |
| OMA | AYTQFCL. |
Enzyme and pathway databases | |
| Reactome | REACT_17015. Metabolism of proteins. |
| UniPathway | UPA00196. |
Gene expression databases | |
| ArrayExpress | Q9NUD9. |
| Bgee | Q9NUD9. |
| CleanEx | HS_PIGV. |
| Genevestigator | Q9NUD9. |
| GermOnline | ENSG00000060642. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR007315. GPI_Mannosyltransferase_2-like. [Graphical view] |
| PANTHER | PTHR12468. PTHR12468. 1 hit. |
| Pfam | PF04188. Mannosyl_trans2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 55650. |
| NextBio | 60346. |
| SOURCE | Search... |
Entry information
| Entry name | PIGV_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NUD9 Secondary accession number(s): D3DPL2 Q9NX26 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
